Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-17T18:32:20.389Z Has data issue: false hasContentIssue false

15 - Elimination of OHSS by GnRH Agonist and Freezing Embryos

Published online by Cambridge University Press:  31 March 2017

By
Basil C. Tarlatzis ,
Julia Bosdou  and
Stratis Kolibianakis
Edited by
Botros Rizk  and
Jan Gerris
Botros Rizk
Affiliation:
University of South Alabama
Jan Gerris
Affiliation:
Universiteit Gent, Belgium
Get access
Type
Chapter
Information
Complications and Outcomes of Assisted Reproduction , pp. 149 - 163
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abramov, Y., Elchalal, U. and Schenker, J. G. Severe OHSS: An ‘epidemic’ of severe OHSS: a price we have to pay? Hum Reprod, 1999; 14(9): 2181–83.CrossRefGoogle Scholar
Devroey, P., Polyzos, N. P. and Blockeel, C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod, 2011; 26(10): 2593–97.CrossRefGoogle ScholarPubMed
Pierce, J.G.P. and Parsons, T. F. Glycoprotein hormones: structure and function. Annu Rev Biochem, 1981; 50: 465–95.CrossRefGoogle ScholarPubMed
Lanzone, A., Fulghesu, A. M., Apa, R., Caruso, A. and Mancuso, S. LH surge induction by GnRH agonist at the time of ovulation. Gynecol Endocrinol, 1989; 3(3): 213–20.CrossRefGoogle ScholarPubMed
Fauser, B. C., de Jong, D., Olivennes, F., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab, 2002; 87(2): 709–15.CrossRefGoogle ScholarPubMed
Itskovitz, J., Boldes, R., Levron, J., et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril, 1991; 56(2): 213–20.CrossRefGoogle ScholarPubMed
Kol, S., Lewit, N. and Itskovitz-Eldor, J. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications. Hum Reprod, 1996; 11(6): 1143–44.CrossRefGoogle ScholarPubMed
Casper, R. F. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome? Hum Reprod, 1996; 11(6): 1144–46.CrossRefGoogle ScholarPubMed
Humaidan, P., Bredkjaer, H. E., Bungum, L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod, 2005; 20(5): 1213–20.Google ScholarPubMed
Schultze-Mosgau, A., Schroer, A., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod, 2005; 20(10): 2887–92.Google Scholar
Griesinger, G., Diedrich, K., Devroey, P. and Kolibianakis, E. M. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update, 2006; 12(2): 159–68.CrossRefGoogle ScholarPubMed
Griesinger, G., Kolibianakis, E. M., Papanikolaou, E. G., et al. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen–thawed embryo replacement cycles. Fertil Steril, 2007; 88(3): 616–21.CrossRefGoogle ScholarPubMed
Engmann, L. and Benadiva, C. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger. Semin Reprod Med, 2010; 28(6): 506–12.CrossRefGoogle ScholarPubMed
Tesarik, J., Hazout, A. and Mendoza, C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online, 2003; 7(1): 59–64.CrossRefGoogle ScholarPubMed
Licht, P., Neuwinger, J., Fischer, O., Siebzehnrubl, E. and Wildt, L. VEGF plasma pattern in ovulation induction: evidence for an episodic secretion and lack of immediate effect of hCG. Experimental and Clinical Endocrinology & Diabetes, 2002; 110: 130–33.CrossRefGoogle ScholarPubMed
Casper, R. F. and Yen, S.S. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science, 1979; 205: 408–10.CrossRefGoogle ScholarPubMed
Kolibianakis, E. M., Griesinger, G. and Venetis, C. A. GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update, 2012; 18(2): 228–29; author reply 229–30.CrossRefGoogle ScholarPubMed
Humaidan, P., Bungum, L., Bungum, M. and Yding Andersen, C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online, 2006; 13(2): 173–78.CrossRefGoogle ScholarPubMed
Humaidan, P., Ejdrup Bredkjaer, H., Westergaard, L. G. and Yding Andersen, C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril, 2010; 93(3): 847–54.CrossRefGoogle Scholar
Humaidan, P., Polyzos, N.P., Alsbjerg, B., et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod, 2013; 28(9): 2511–21.CrossRefGoogle ScholarPubMed
Radesic, B. and Tremellen, K. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum Reprod, 2011; 26(12): 3437–42.CrossRefGoogle ScholarPubMed
Seyhan, A., Ata, B., Polat, M., et al. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Hum Reprod, 2013; 28(9): 2522–28.CrossRefGoogle ScholarPubMed
Castillo, J. C., Dolz, M., Bienvenido, E., et al. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod Biomed Online, 2010; 20(2): 175–81.CrossRefGoogle ScholarPubMed
Papanikolaou, E. G., Verpoest, W., Fatemi, H., et al. A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil Steril, 2011; 95(3): 1174–77.CrossRefGoogle ScholarPubMed
Decleer, W., Osmanagaoglu, K., Seynhave, B., et al. Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial. Facts Views Vis Obgyn, 2014; 6(4): 203–09.Google ScholarPubMed
Lin, M. H., Wu, F. S., Lee, R. K., et al. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril, 2013; 100(5): 1296–302.CrossRefGoogle ScholarPubMed
Griffin, D., Benadiva, C., Kummer, N., et al., Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril, 2012; 97(6): 1316–20.CrossRefGoogle ScholarPubMed
Shapiro, B. S., Daneshmund, S. T., Garner, F. C., Aguirre, M. and Thomas, S. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril, 2008; 90(1): 231–33.CrossRefGoogle ScholarPubMed
Pirard, C., Donnez, J. and Loumaye, E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod, 2006; 21(7): 1894–900.CrossRefGoogle ScholarPubMed
Engmann, L., DiLuigi, A., Schmidt, D., et al., The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril, 2008; 89(1): 84–91.CrossRefGoogle ScholarPubMed
Babayof, R., Margalioth, E. J., Huleihel, M., et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod, 2006; 21(5): 1260–65.CrossRefGoogle ScholarPubMed
Griesinger, G., von Otte, S., Schroer, A., et al. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod, 2007; 22(5): 1348–52.CrossRefGoogle ScholarPubMed
Griesinger, G., Berndt, H., Schultz, L., Depenbusch, M. and Schultze-Mosgau, A. Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study. Eur J Obstet Gynecol Reprod Biol, 2010; 149(2): 190–94.CrossRefGoogle ScholarPubMed
Griesinger, G., Schultz, L., Bauer, T., et al. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study. Fertil Steril, 2011; 95(6): 2029–33.CrossRefGoogle Scholar
Griesinger, G., Berndt, H., Schultz, L., et al. Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study. Reprod Biomed Online, 2011; 22(2): 133–39.CrossRefGoogle Scholar
Acevedo, B., Gomez-Palomares, J. L., Ricciarelli, E. and Hernandez, E. R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril, 2006; 86(6): 1682–87.CrossRefGoogle Scholar
Galindo, A., Bodri, A., Guillén, J. J., et al. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol, 2009; 25(1): 60–66.CrossRefGoogle ScholarPubMed
Melo, M., Busso, C. E., Bellver, J., et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online, 2009; 19(4): 486–92.CrossRefGoogle Scholar
Sismanoglu, A., Tekin, H. I., Erden, H. F., et al., Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial. J Assist Reprod Genet, 2009; 26(5): 251–56.CrossRefGoogle ScholarPubMed
Bodri, D., Guillén, J. J., Galindo, A., et al. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril, 2009; 91(2): 365–71.CrossRefGoogle ScholarPubMed
Bodri, D., Guillén, J. J., Trullenque, M., et al. Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril, 2010; 93(7): 2418–20.CrossRefGoogle ScholarPubMed
Castillo, J. C., Dolz, M., Moreno, J., et al. Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation. Reprod Biomed Online, 2012; 24(2): 247–50.CrossRefGoogle Scholar
Hernandez, E. R., Gomez-Palomares, J. L. and Ricciarelli, E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril, 2009; 91(4 Suppl): 1358–61.CrossRefGoogle ScholarPubMed
Reddy, J., Turan, V., Bedoschi, G., Moy, F. and Oktay, K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet, 2014; 31(7): 927–32.CrossRefGoogle ScholarPubMed
Manzanares, M. A., Gomez-Palomares, J. L., Ricciarelli, E. and Hernandez, E. R. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril, 2010; 93(4): 1215–19.CrossRefGoogle Scholar
Fatemi, H. M., Popovic-Todorovic, B., Humaidan, P., et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol. Fertil Steril, 2014; 101(4): 1008–11.CrossRefGoogle ScholarPubMed
Gurbuz, A. S., Gode, F., Ozcimen, N. and Isik, A. Z. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases. Reprod Biomed Online, 2014; 29(5): 541–44.CrossRefGoogle Scholar
Shapiro, B. S., Daneshmund, S. T., Garner, F. C., et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders. Fertil Steril, 2011; 96(2): 344–48.Google ScholarPubMed
Shapiro, B.S., Daneshmund, S. T., Garner, F. C., et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfers in high responders. Fertil Steril, 2011; 96(2): 516–18.Google ScholarPubMed
Maheshwari, A., Pandey, S., Shetty, A., Hamilton, M. and Bhattacharya, S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril, 2012; 98(2): 368–77.CrossRefGoogle ScholarPubMed
Pinborg, A., Henningsen, A. A., Loft, A., et al. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique? Hum Reprod, 2014; 29(3): 618–27.CrossRefGoogle ScholarPubMed
Gulekli, B., Gode, F., Sertkaya, Z. and Isik, A. Z. Gonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series. J Turk Ger Gynecol Assoc, 2015; 16(1): 35–40.CrossRefGoogle Scholar
Fatemi, H. M. and Garcia-Velasco, J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril, 2015; 103(4): 870–73.CrossRefGoogle ScholarPubMed
Humaidan, P., Engmann, L. and Benadiva, C. Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril, 2015; 103(4): 879–85.CrossRefGoogle ScholarPubMed
Shapiro, B. S. and Andersen, C. Y. Major drawbacks and additional benefits of agonist trigger – not ovarian hyperstimulation syndrome related. Fertil Steril, 2015; 103(4): 874–78.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×